We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Inspiration Healthcare Group Plc | LSE:IHC | London | Ordinary Share | GB00BXDZL105 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 31.50 | 31.00 | 32.00 | 31.50 | 31.50 | 31.50 | 5,000 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Home Health Care Services | 41.23M | 272k | 0.0040 | 78.75 | 21.48M |
TIDMIHC
RNS Number : 7480Z
Inspiration Healthcare Group PLC
23 May 2019
Inspiration Healthcare Group plc
("Inspiration Healthcare", or the "Company")
Publication of Annual Report and Notice of AGM
Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, announces that its report and accounts for the year ended 31 January 2019 have been sent to shareholders and an electronic copy is available from the Company's website https://www.inspiration-healthcare.com.
The Company also confirms that its Annual General Meeting will be held on 27 June at 11.30am at the Company's Head Office, 2 Satellite Business Village, Fleming Way, Crawley, West Sussex, RH10 9NE.
Enquiries:
Inspiration Healthcare Group Tel: 01455 840555 plc Neil Campbell, Chief Executive Officer Mike Briant, Chief Financial Officer Nominated Adviser & Broker Tel: 0207 397 8900 Cenkos Securities plc Mark Connelly Cameron MacRitchie ------------------- Cadogan PR Tel: 07771 713608 Alex Walters -------------------
About Inspiration Healthcare
Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.
Through investment in research and development the Company has 6 key own brand products that can be used within the first 6 hours of life to help premature and sick babies; helping with assessment, resuscitation, stabilisation as well as preventing brain damage. Additionally the company has its own range of products for maintaining normothermia pre- during and post-surgery.
With product availability extending to over 50 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.
In the UK and Ireland the Company has a direct sales team selling Inspiration Branded and complementary products from third parties, with an additional range of home healthcare products. This is supported by Technical Support for planned preventative maintenance and emergency assistance.
Further information on Inspiration Healthcare can be seen at www.inspiration-healthcare.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
NOAUASSRKNAVUAR
(END) Dow Jones Newswires
May 23, 2019 02:01 ET (06:01 GMT)
1 Year Inspiration Healthcare Chart |
1 Month Inspiration Healthcare Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions